2006 Pharmaceutical Manufacturing Capital Investment Survey

1. Key concerns for your organization this year

1. Please rate these concerns, based on how important you believe they are to your organization.

	Top priority	Important	Fairly important	Not a priority
Raw material costs and quality	*Please rate these concerns, based on how important you believe they are to your organization. Raw material costs and quality Top priority	Raw material costs and quality Important	Raw material costs and quality Fairly important	Raw material costs and quality Not a priority
Manufacturing efficiency	Manufacturing efficiency Top priority	Manufacturing efficiency Important	Manufacturing efficiency Fairly important	Manufacturing efficiency Not a priority
Energy costs	Energy costs Top priority	Energy costs Important	Energy costs Fairly important	Energy costs Not a priority
Increasing new product pipeline	Increasing new product pipeline Top priority	Increasing new product pipeline Important	Increasing new product pipeline Fairly important	Increasing new product pipeline Not a priority
Expanding into new markets (geographical)	Expanding into new markets (geographical) Top priority	Expanding into new markets (geographical) Important	Expanding into new markets (geographical) Fairly important	Expanding into new markets (geographical) Not a priority
Expanding into new markets (therapeutic)	Expanding into new markets (therapeutic) Top priority	Expanding into new markets (therapeutic) Important	Expanding into new markets (therapeutic) Fairly important	Expanding into new markets (therapeutic) Not a priority
Reducing product prices	Reducing product prices Top priority	Reducing product prices Important	Reducing product prices Fairly important	Reducing product prices Not a priority
Ensuring quality	Ensuring quality Top priority	Ensuring quality Important	Ensuring quality Fairly important	Ensuring quality Not a priority
Ensuring compliance	Ensuring compliance Top priority	Ensuring compliance Important	Ensuring compliance Fairly important	Ensuring compliance Not a priority
Capacity utilization and downtime elimination	Capacity utilization and downtime elimination Top priority	Capacity utilization and downtime elimination Important	Capacity utilization and downtime elimination Fairly important	Capacity utilization and downtime elimination Not a priority
Reducing equipment and material costs	Reducing equipment and material costs Top priority	Reducing equipment and material costs Important	Reducing equipment and material costs Fairly important	Reducing equipment and material costs Not a priority
Increased international competition	Increased international competition Top priority	Increased international competition Important	Increased international competition Fairly important	Increased international competition Not a priority
Competition from generics	Competition from generics Top priority	Competition from generics Important	Competition from generics Fairly important	Competition from generics Not a priority
Workforce training and skills shortages	Workforce training and skills shortages Top priority	Workforce training and skills shortages Important	Workforce training and skills shortages Fairly important	Workforce training and skills shortages Not a priority

2. Have we left anything out? Please mention briefly.

Have we left anything out? Please mention briefly.

Check out our sample surveys and create your own now!

form {display:none;} #jserror {text-align:center;margin-top:50px;}Javascript is required for this site to function, please enable.